PIKFYVE and cancer: Thus, PIKFYVE inhibitors can selectively terminate autophagy‐dependent cancer cells and pluripotent cancer stem cells under conditions where nonmalignant cells remain viable [4, 7, 9, 11, 12, 13, 14].